Kallikrein gene

Details for Australian Patent Application No. 2001287384 (hide)

Owner Mount Sinai Hospital

Inventors Diamandis, Eleftherios P.; Yousef, George M.

Agent Shelston IP

Pub. Number AU-B-2001287384

PCT Pub. Number WO02/14485

Priority 60224853 11.08.00 US

Filing date 10 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 29 March 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

21 October 2004 Amendment Made

  The nature of the amendment is: Amend the invention title to Kallikrein gene.

29 March 2007 Application Accepted

  Published as AU-B-2001287384

2 August 2007 Standard Patent Sealed

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001287385

2001287383-ADJUSTABLE SUSPENSION SYSTEM